National MS Society : Headlines What's new

• Tysabri Improved Quality of Life among Participants in Pivotal Clinical Trials in MS
• Great Strides Moved MS Research Forward During 2007
• Study Enrolling to Evaluate Effects of Tysabri on Fatigue and Cognition
• Study Suggests MS Drugs Delay Progression of Disability in Relapsing MS
• Study Suggests Copaxone Treatment Reduces Risk of Developing MS
• National Multiple Sclerosis Society Launches Drug Development Initiative

http://www.nationalmssociety.org/site/PageServer?pagename=HOM_NEWS_homepage&s_oo=cQNJeSm-btacjuvPqkOe7A